Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Advanced Psychiatry is a specialized mental health clinic based in Fort Worth, Texas, led by board-certified psychiatrist Dr. Diana Ghelber. The center focuses on treating complex and treatment-resistant psychiatric conditions, including major depressive disorder, PTSD, and OCD. It offers a range of advanced therapeutic modalities such as BrainsWay Deep Transcranial Magnetic Stimulation (TMS), intravenous ketamine infusions, and PRISM for PTSD, a novel neurofeedback therapy. The institute emphasizes an integrative approach, combining traditional medication management and psychotherapy with innovative biological interventions to help patients who have not responded to standard treatments. Additionally, the clinic provides specialized care for chronic pain, addiction, and eating disorders through a personalized, evidence-based framework.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Advanced Psychiatry.